Dynamic Impedance Cardiac Function Characterization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for configuring pacemakers and cardiac resynchronization therapy devices rely on time-consuming echocardiographic evaluations and rough estimates from intra-cardiac electrograms, which may not accurately reflect a patient's cardiac function, especially during ambulatory and active states.

Innovation Solution

A method and system that collect cardiac signals and dynamic impedance data to characterize cardiac function by identifying timing features and analyzing morphologic characteristics, allowing for the adjustment of therapy parameters to optimize venous return and right ventricular function levels.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If echocardiographic evaluation is used to determine pacemaker and CRT parameters, then measurement precision is improved, but time consumption increases and productivity decreases

Engineering Contradiction:
Improvecardiac function measurement precisionVSAvoidevaluation time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent replaces the mechanical/echocardiographic imaging system with an electrical impedance-based measurement system. The impedance sensor measures electrical properties of the heart tissue to derive cardiac function parameters, eliminating the need for time-consuming echocardiographic imaging while maintaining measurement precision through sophisticated signal processing and correlation analysis.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent transforms the measurement approach by changing from anatomical/imaging parameters (echocardiography) to electrical/functional parameters (impedance). By measuring impedance changes during the cardiac cycle and correlating them with cardiac function, the system achieves rapid, continuous monitoring without the time constraints of traditional echocardiographic evaluation.

Inventive Principle:
Principle #35Parameter changes

2Ease of operation

If P wave duration is used to estimate intra-atrial conduction time, then ease of operation is improved, but measurement precision deteriorates

Engineering Contradiction:
Improveparameter estimation simplicityVSAvoidintra-atrial conduction time estimation accuracy
Core Design Contradiction:
Ease of operationVSMeasurement precision

Solution Approach 1:

The patent introduces impedance as an intermediary measurement that directly reflects cardiac function without requiring indirect estimations through P wave duration. The impedance sensor provides a more direct and accurate measure of conduction properties and cardiac mechanics, serving as a better mediator between the electrical signals and the physiological parameters of interest.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The system continuously monitors impedance changes and uses this feedback to dynamically adjust and optimize pacemaker and CRT parameters. This closed-loop approach allows real-time refinement of timing parameters based on actual cardiac response, improving both the simplicity and accuracy of parameter estimation compared to static P wave-based methods.

Inventive Principle:
Principle #23Feedback

3Measurement precision

If parameters are optimized for clinic settings, then measurement precision is improved, but adaptability to ambulatory states deteriorates

Engineering Contradiction:
Improveparameter optimization accuracyVSAvoidparameter applicability across activity states
Core Design Contradiction:
Measurement precisionVSAdaptability or versatility

Solution Approach 1:

The patent implements dynamic parameter optimization by continuously monitoring impedance changes during different activity states. The system adapts timing parameters in real-time based on the patient's current physiological state, whether at rest or during ambulatory activity. This dynamic adjustment ensures that parameters remain optimized for the current condition rather than being fixed for a single clinic setting.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The system performs preliminary characterization of cardiac function using impedance measurements during clinic visits, establishing baseline parameters. These preliminary data are then used to configure the pacemaker/CRT device with parameters that can be automatically adjusted during ambulatory activity, ensuring continuous optimization without requiring re-optimization for each activity state.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables more precise and personalized cardiac function characterization and therapy configuration, improving atrial filling, ventricular emptying, and hemodynamic support by correlating dynamic impedance with cardiac function indicators, even in ambulatory and active states.

Implementation Method 1

collecting dynamic impedance (DI) data over at least one cardiac cycle (CC), designated by the timing FOI, along at least one of i) a venous return (VR) vector or ii) a right ventricular function (RVF) vector

Methodology Applied
Scientific EffectElectrical Impedance: Electrical Resistance

Data Source

PatentUS9179846B2Method and system for characterizing cardiac function based on dynamic impedance
Publication Date: 2015.11.10 PACESETTER INC
  • US9179846B2 patent drawing
  • US9179846B2 patent drawing
  • US9179846B2 patent drawing

AI summary

A method and system are provided for characterizing cardiac function. The method and system comprise collecting cardiac signals associated with electrical or mechanical behavior of a heart over at least one cardiac cycle; identifying a timing feature of interest (FOI) from the cardiac signals; collecting dynamic impedance (DI) data over at least one cardiac cycle (CC), designated by the timing FOI, along at least one of i) a venous return (VR) vector or ii) a right ventricular function (RVF) vector; and analyzing at least one morphologic characteristic from the DI data based on at least one of i) a VR-DI correlation metric to obtain a VR indicator associated with the CC or ii) a RVF-DI correlation metric to obtain a RVF indicator associated with CC.